Open AccessInhaled Nitric Oxide for Respiratory Failure in Preterm Infants
Author(s) -
Roger F. Soll
Publication year - 2012
Publication title -
neonatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.399
H-Index - 84
eISSN - 1661-7819
pISSN - 1661-7800
DOI - 10.1159/000338552
Subject(s) - medicine , bronchopulmonary dysplasia , retinopathy of prematurity , randomized controlled trial , respiratory failure , cochrane library , pediatrics , population , intraventricular hemorrhage , placebo , gestational age , pregnancy , pathology , environmental health , biology , genetics , alternative medicine
Inhaled nitric oxide (iNO) is effective in term infants with hypoxic respiratory failure. The pathophysiology of respiratory failure and the potential risks of iNO differ substantially in preterm infants, necessitating study in this population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom